BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu Y, Sharma A, Chen Y, Zhou H. What We Can Learn from Current Inflammatory Bowel Disease (IBD) Biological Therapy—Dose Regimen and Others. Curr Pharmacol Rep 2019;5:115-30. [DOI: 10.1007/s40495-019-00180-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Shao J, Xu Z, Xu Y. Integrated Population Pharmacokinetic Analysis of Ustekinumab Across Multiple Immune-Mediated Inflammatory Disease Populations and Healthy Subjects. Eur J Drug Metab Pharmacokinet 2022. [PMID: 35442011 DOI: 10.1007/s13318-022-00768-7] [Reference Citation Analysis]